American Oncology Network, Inc. Class A Common Stock
AONC
AONC was delisted on the 7th of June, 2024.
3 hedge funds and large institutions have $142K invested in American Oncology Network, Inc. Class A Common Stock in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 12 closing their positions.
77% less funds holding
Funds holding: 13 → 3 (-10)
83% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 12
99% less capital invested
Capital invested by funds: $18.4M → $142K (-$18.3M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$31.2K |
| 2 |
JP Morgan Chase
New York
|
+$3.97K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$6.12M |
| 2 |
SCM
Saba Capital Management
New York
|
-$2.12M |
| 3 |
AIMCA
Alberta Investment Management Corp (AIMCo)
Edmonton,
Alberta, Canada
|
-$1.81M |
| 4 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$1.55M |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$1.47M |
AONC Hedge Fund Activity: Q3 2023 in Review
3 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in American Oncology Network, Inc. Class A Common Stock (AONC) for Q3 2023, worth a combined $142K — down 99% from $18.4M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of AONC and 2 opened new positions — a net loss of 10 holders — while 1 trimmed existing stakes and 0 added.
The largest buyer was UBS Group, opening a new position worth an estimated $31.2K. The largest seller was CVI Holdings, exiting entirely with an estimated $6.12M sold.
- 3 institutional investors held American Oncology Network, Inc. Class A Common Stock (AONC) as of Q3 2023, down from 13 in Q2 2023.
- Funds reported $142K of American Oncology Network, Inc. Class A Common Stock stock for Q3 2023, down 99% quarter-over-quarter.
- 2 funds opened new American Oncology Network, Inc. Class A Common Stock positions in Q3 2023 and 12 closed out, a net change of -10 holders.
- The largest American Oncology Network, Inc. Class A Common Stock buyer in Q3 2023 was UBS Group, an estimated $31.2K added.
- The largest American Oncology Network, Inc. Class A Common Stock seller in Q3 2023 was CVI Holdings, an estimated $6.12M sold.
Based on aggregated 13F filings for Q3 2023.